Rituximab combined to ACVBP (R-ACVBP) supported by pegfilgrastim as a new inductive treatment followed by high-dose consolidative autotransplantation (HDC) for poor risk diffuse large B-cell lymphoma (DLBCL) in first-line. Results of LNH 03-39B. A GELA study

被引:1
作者
Belhadj, Karim [1 ]
Jais, Jean-Philipp [2 ]
Feugier, Pierre [3 ]
Gisselbrecht, Christian [4 ]
Recher, Christian [5 ]
Casasnova, Olivier [6 ]
Coiffier, Bertrand [7 ]
Sebban, Catherine [8 ]
Delmer, Alain [9 ]
Morschhauser, Franck [10 ]
Canioni, Daniele [2 ]
Tilly, Herve [11 ]
Haioun, Corinne [1 ]
机构
[1] Hop Henri Mondor, F-94010 Creteil, France
[2] Hop Necker Enfants Malad, Paris, France
[3] Brabois Hosp, Nancy, France
[4] St Louis Hosp, Paris, France
[5] Purpan Hosp, Toulouse, France
[6] Le Bocage Hosp, Dijon, France
[7] Hosp Ctr, Pierre Benite, France
[8] Ctr Leon Berard, F-69373 Lyon, France
[9] Hop Robert Debre, Reims, France
[10] Oscar Lambret Hosp, Lille, France
[11] Ctr Henri Becquerel, F-76038 Rouen, France
关键词
D O I
10.1182/blood.V110.11.3437.3437
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
3437
引用
收藏
页码:1007A / 1007A
页数:1
相关论文
empty
未找到相关数据